SAM
CPXX

Sandell Asset Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Sandell Asset Management’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-448,293
Closed -$13.5M – 25
2016
Q2 		$13.5M Buy
+448,293
New +$9.1M 3% 15

Sandell Asset Management's CPXX Position: Q3 2016 in Review

Sandell Asset Management sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 448,293 shares — an estimated $13.5M sold.

Sandell Asset Management first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $13.5M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Sandell Asset Management reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Sandell Asset Management sold 448,293 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $13.5M.
  • Sandell Asset Management first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • Sandell Asset Management's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $13.5M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Sandell Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.